Aclysiran, an RNAi therapeutic agent targeting ACLY, treats hypercholesterolemia and atherosclerosis in ApoE–/– mice - Meijie Chen; Peter J. Little; Sudong Kong; Maciej Banach; Jianping Weng; Suowen Xu (Acta Pharmaceutica Sinica B)